Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, Uttar Pradesh, India.
Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
J Biomol Struct Dyn. 2022 May;40(8):3642-3654. doi: 10.1080/07391102.2020.1848629. Epub 2020 Dec 9.
Cystatins are classical competitive inhibitors of C1 family cysteine proteases (papain family). Phytocystatin superfamily shares high sequence homology and typical tertiary structure with conserved glutamine-valine-glycine (Q-X-V-X-G) loop blocking the active site of C1 proteases. Here, we develop a cysteine-bounded cyclic peptide (CYS-cIHL) and linear peptide (CYS-IHL), using the conserved inhibitory hairpin loop amino acid sequence. Using an in silico approach based on modeling, protein-peptide docking, molecular dynamics simulations and calculation of free energy of binding, we designed and validated inhibitory peptides against falcipain-2 (FP-2) and -3 (FP-3), cysteine proteases from the malarial parasite . Falcipains are critical hemoglobinases of that are validated targets for the development of antimalarial therapies. CYS-cIHL was able to bind with micromolar affinity to FP-2 and modulate its binding with its substrate, hemoglobin in and assays. CYS-cIHL could effectively block parasite growth and displayed antimalarial activity in culture assays with no cytotoxicity towards human cells. These results indicated that cyclization can substantially increase the peptide affinity to the target. Furthermore, this can be applied as an effective strategy for engineering peptide inhibitory potency against proteases.
半胱氨酸蛋白酶抑制剂是经典的 C1 家族半胱氨酸蛋白酶(木瓜蛋白酶家族)的竞争性抑制剂。植物半胱氨酸蛋白酶抑制剂超家族与保守的谷氨酰胺-缬氨酸-甘氨酸(Q-X-V-X-G)环具有高度的序列同源性和典型的三级结构,该环阻止 C1 蛋白酶的活性位点。在这里,我们使用保守的抑制发夹环氨基酸序列开发了一种半胱氨酸结合的环状肽(CYS-cIHL)和线性肽(CYS-IHL)。我们通过基于建模、蛋白-肽对接、分子动力学模拟和结合自由能计算的计算方法设计并验证了针对疟原虫的半胱氨酸蛋白酶 falcipain-2(FP-2)和 -3(FP-3)的抑制肽。FP-2 和 -3 是疟原虫的关键血红蛋白酶,是开发抗疟治疗方法的验证靶点。CYS-cIHL 能够以微摩尔亲和力与 FP-2 结合,并调节其与血红蛋白的结合,血红蛋白是 和 测定中的底物。CYS-cIHL 能够有效抑制寄生虫的生长,并在无细胞毒性的情况下在培养测定中表现出抗疟活性。这些结果表明,环化可以大大提高肽与靶标的亲和力。此外,这可以作为一种有效的策略,用于设计针对蛋白酶的具有增强抑制效力的肽。